4Picano E, Abbracchio MP. European stroke prevention study 2 results:serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation? Trends Pharmacol Sci, 1998; 19(1):14～16 被引量：1
5Sivenius J, Cunha L, Diener HC et al. Second European stroke prevention study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group. Acta Neurol Scand, 1999; 99(1):54～60 被引量：1
6Wilterdink JL, Easton JD. Dipyridamole plus aspirin in cerebrovasular disease. Arch Neurol, 1999; 56(9):1087～1092 被引量：1
7Anikin VV. Dipyridamole (Curantil) treatment of anginal patients: results of treatment for many years. Ter Arkh, 1999; 71(8):34～37 被引量：1
8Research Group for Antiarrhythmic Drug Therapy. Atrial fibrillation and thromboembolishm: a multicenter cooperative study. Research group for antiarrhythmic drug therapy. J Cardiol, 1998; 31(4):227～238 被引量：1
9Heintzen MP, Heidland UE, Klimek WJ et al. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA:a prospective randomised trial. Heart, 2000; 83(5):551～556 被引量：1
10Yoshida Y, Hirai M, Yamada T et al. Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias: evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. Circulation, 2000; 101(6):624～630 被引量：1
